P/f Bakkafrost (OSL: BAKKA) — Faroese Returns Must Fund Scottish Proof

Published: 2026-09-12 · Verdict: Hold · Research confidence: High (82%)

Executive conclusion

Analyst Take

HOLD at the verified 11 September 2026 official-session close of NOK 448.20; estimated probability-weighted value is approximately NOK 475–500; an accumulation range begins below roughly NOK 380. These NOK figures are analyst estimates, not company guidance. The central investment tension is unusually clear: Bakkafrost owns a high-quality, scarce-licence and deeply integrated Faroese salmon operation, but shareholders are also funding a Scottish turnaround that remains economically unproved almost seven years after the 2019 acquisition.

The Faroese evidence is strong. Bakkafrost coordinates broodstock, large-smolt production, feed formulation, marine farming, freshwater treatment vessels, harvesting, processing, logistics and sales within a compact geography. In Q2 2026, the Faroese region harvested 26,749 tonnes and generated all-inclusive operational EBIT of DKK 15.38/kg. Ring-site cost declined to DKK 29.96/kg, harvest weight reached 5.5kg and management reported low mortality and controlled sea lice. These outcomes are consistent with a real operating advantage, although they do not prove that every internal feed or service segment earns a superior standalone return. [S1][S4]

Scotland is the disconfirming asset. Its all-inclusive Q2 result was negative DKK 44.13/kg on only 3,145 tonnes of harvest. Low utilization, fallow-site expense, vessel and harvesting fixed costs, and biological problems in one externally supplied smolt batch all contributed. Applecross was operating at only about 35% of intended capacity; management expects full production and stocking around Q2 2027. That forecast creates considerable operating leverage, but it is still a management hypothesis. Mowi’s Scottish-origin operation earned EUR 1.80/kg in the same quarter, on 26,680 tonnes and strong biological performance. Scottish weather, regulation and location therefore cannot by themselves explain Bakkafrost’s loss. The gap points to cohort quality, site use, biological control and fixed-cost absorption. [S1][S4][S7]

The draft’s cash-flow and valuation characterization required correction. Filing-derived trailing cash from operations through June 2026 was approximately DKK 1.42 billion and capital expenditure approximately DKK 1.03 billion, producing about DKK 385 million before lease principal and about DKK 210 million after estimated trailing lease payments. Cash generation is therefore positive, not nil, but the after-lease equity yield is only about 1.1%. At NOK 448.20, issued-share market capitalization is approximately NOK 26.62 billion. Using the 11 September exchange rate, that is roughly DKK 18.46 billion. Adding DKK 4.04 billion of net interest-bearing debt gives enterprise value of DKK 22.50 billion excluding leases, or DKK 23.29 billion including lease liabilities. Against trailing operational EBITDA of DKK 1.965 billion and operational EBIT of DKK 1.134 billion, the respective multiples are approximately 11.5x and 19.8x excluding leases. Trailing adjusted earnings imply 30.9x. [S1][S2][S11][S16]

Those multiples are not distressed. They discount substantial Scottish difficulty, but they also presume that the consolidated business progresses beyond 2025’s 5.1% reported ROCE. The central scenario assumes late-decade harvest near 150,000 tonnes, all-inclusive operational EBIT around DKK 15/kg, no material equity issuance and investment spending broadly within the announced DKK 5 billion programme. The bear case assumes recurring Scottish losses, higher debt and only about 120,000 tonnes at DKK 8/kg. The bull case requires Scotland to become consistently profitable, harvest approaching 162,000 tonnes and group economics above DKK 20/kg. Discounted and weighted 35% bear, 50% central and 15% bull, those paths support approximately NOK 475–500 per share.

The strongest counter-case is that the operational inflection is already visible. H1 2026 operational EBIT rose to DKK 816 million from DKK 570 million; Faroese volume and biology were strong; Scottish absolute incident cost declined; Applecross transfers increased; and industry supply forecasts point to slower growth after 2025’s exceptional expansion. The strongest rebuttal is that the improvement is concentrated in the Faroes while Scotland remains loss-making, the production-tax burden is excluded from operational EBIT, debt has increased and the large-smolt payoff has not been disclosed through matched cohort returns. [S1][S2][S10]

Investment conviction is moderate. Evidence quality is high for audited 2025 financials, the corrected Q2 filing, share price and current balance sheet; moderate for peer comparisons because adjusted-profit definitions differ; and only moderate-to-low for Scottish normalization because management does not disclose matched survival, feed-conversion, incident-cost and fully allocated return data by smolt source and transfer cohort. The factor model was unavailable. That absence is a data limitation, not evidence of neutral factor exposure, and no beta, alpha, factor score or model-based positioning conclusion is asserted.

The near-term decision sequence is measurable: Applecross utilization and internal smolt weight; post-transfer survival; Scottish incident cost and all-inclusive EBIT/kg; Faroese survival and ring-site cost as volume expands; cumulative investment against the DKK 5 billion plan; and net debt after capital expenditure and dividends. The call would improve after at least two consecutive quarters of positive Scottish all-inclusive operational EBIT, falling incident cost, and stable leverage—or after a materially wider valuation discount. It would deteriorate if large-smolt cohorts remain uneconomic at higher utilization, Faroese biology weakens as stocking expands, net debt approaches three times sustainable operational EBITDA, or the 162,000-tonne ambition requires materially more capital or new equity. [S1][S2][S4]

Stock Price Action — Five-Year Event Map

Bakkafrost closed at NOK 448.20 on 11 September 2026. Company Financials’ split-adjusted series places the highest daily close over the preceding five years at NOK 790 on 27 October 2021 and the lowest at NOK 393 on 18 July 2025. The current close is therefore about 43% below the five-year closing high and 14% above the closing low. The latest 52-week intraday range was approximately NOK 390.80–526.00; NOK 448.20 sits about 42% of the way through that range. Price observations are facts. The event attributions below are interpretations because salmon prices, interest rates, currencies, positioning and company news often moved together. [S11]

• October 2021—five-year closing high near NOK 790. The valuation coincided with constrained salmon supply, favorable pricing and optimism that vertical integration and Scottish expansion would earn attractive returns. The price is verified; assigning the high to any single variable would be false precision.

• 2022—sharp de-rating amid rates and investment risk. The shares fell materially as interest rates rose and investors confronted the capital needed to transform the acquired Scottish estate. Salmon pricing was strong during parts of the year, so the decline was not a simple commodity-price response. The period illustrates that duration and capital intensity affect the equity independently of spot salmon. [S2][S11]

• Spring to autumn 2023—approximately NOK 679 at the end of March to roughly NOK 551 at the beginning of October. Faroese production-tax uncertainty became economically material. The August 2023 regime could charge up to 20% of reference-price revenue and used an index rather than Bakkafrost’s realized contract price. Bakkafrost consequently reduced fixed-price contracting and value-added processing exposure. Tax design plausibly contributed to the de-rating, although the price move cannot be allocated uniquely to it. [S6][S11]

• March 2024—close near NOK 664. Better Faroese biological trends and large-smolt progress supported optimism. The later retreat despite a 24% increase in 2024 harvest is important: tonnes alone do not establish value when realized price, mortality, capital spending and regional returns change. [S2][S11]

• January to July 2025—approximately NOK 637 to the five-year closing low of NOK 393. Global Atlantic salmon harvest increased about 12% in 2025, depressing prices. Bakkafrost also reported Scottish disease, mortality and hatchery problems; its Q2 operational result was only DKK 65 million. These facts are consistent with the drawdown, but rates and sector positioning may also have contributed. [S2][S5][S10][S11]

• July to December 2025—recovery from NOK 393 to a 52-week closing high of NOK 521. Faroese biology remained strong, harvest rose and producers forecast lower future supply growth. The recovery was evidence that expectations changed, not evidence that Scotland had normalized. [S2][S10][S11]

• January to July 2026—approximately NOK 518 to NOK 395. Weak prices, Scottish losses and a capex-heavy programme remained visible. Management retained the late-decade harvest target while acknowledging adjustments to project timing. The shares therefore continued to price execution risk despite stronger Faroese output. [S1][S4][S11]

• 31 August 2026—8.4% one-day decline, from NOK 498 to NOK 456. The corrected Q2 report disclosed DKK 273 million of group operational EBIT but a DKK 139 million Scottish regional loss, negative DKK 44.13/kg and only 35% Applecross utilization. The market reaction is consistent with investors emphasizing the quality and durability of the recovery. That causal interpretation remains inference. [S1][S4][S11][S14]

No factor-model snapshot was supplied. It would be incorrect to replace it with an unrelated public beta or to describe a homemade peer regression as the factor model. Raw price underperformance and event returns remain useful market observations, but they are not factor attribution. The defensible conclusion is narrower: the price already reflects meaningful disappointment, while the post-Q2 gap shows that Scottish execution remains a dominant expectation-setting variable. [S1][S11]

Verdict: The five-year drawdown provides valuation context but is not itself evidence of cheapness. The shares are far below the 2021 high, yet current earnings, cash returns and Scottish execution are also materially weaker than the expectations capitalized at that high. [S1][S2][S11]

Business Overview

Business-understandability answer: The economic engine is understandable—harvested kilograms multiplied by realized price, less feed, mortality, treatment, labor, logistics and fixed processing costs—but fair-value biomass accounting, intersegment transfers and the long biological cycle complicate reported profitability. [S1][S2]

P/F Bakkafrost is a Faroese public limited company whose ordinary shares are listed on Euronext Oslo under BAKKA. The security is a foreign ordinary share, not an ADR, MLP, partnership or K-1 issuer. Investors must separately assess dividend withholding, treaty relief, brokerage custody and domicile-specific tax treatment. The consolidated accounts use DKK as functional and presentation currency, while the shares and dividends delivered through Oslo are quoted in NOK. [S2][S11]

The value chain has seven reported operating segments and five broad economic activities. Havsbrún sources marine raw material and manufactures fishmeal, fish oil and feed. Freshwater facilities produce eggs and smolt in the Faroe Islands and Scotland. Farming segments grow salmon at licensed marine sites. The services segment operates wellboats, treatment and support vessels, harvesting, packaging and bioenergy activities. Sales & Other processes and distributes salmon through facilities in the Faroes, Scotland, Denmark and the United States. Segment revenue is heavily intercompany: in 2025, FOF generated DKK 2.604 billion of total revenue, but DKK 2.264 billion was internal, and 99% of feed volume was used within the group. [S2]

External revenue comes principally from salmon sales. Fishmeal, fish oil, feed, processing, logistics and ancillary activities contribute smaller external amounts. Revenue is recognized when control transfers to the customer; contract assets and liabilities are generally immaterial because contracts are short. No customer met IFRS 8’s major-customer threshold in either 2025 or 2024. Customer concentration is therefore modest, but revenue is not recurring in the contractual sense. Each year’s sales depend on harvestable biomass, biological performance, market price, weight, quality grade and sales mix. [S2]

Revenue-stability answer: Bakkafrost has broad customer diversification but transactional revenue; salmon prices, biological availability, harvest timing, quality and contract mix can move annual revenue sharply, and only 15–25% of expected 2026 harvest was intended to be covered by fixed-price contracts. [S1][S2]

The 2023–24 production-tax design reduced the value of fixed contracts. Tax was calculated from a market reference price rather than actual realization. If Bakkafrost had fixed a low selling price and the reference price subsequently rose, the tax charge could increase while contract margin did not. Management cut contract exposure and adjusted value-added processing. From 2025 the maximum revenue-tax rate fell from 20% to 7.5%, but a 12% additional corporate tax was introduced for Faroese marine farming. The agreement runs politically through 2032 and improves visibility, yet the 15–25% 2026 contract target shows that spot exposure remains substantial. [S1][S6]

The Faroese region is the current profit engine. Compact geography and control of feed, freshwater, marine farming, treatment, harvesting and logistics allow the company to coordinate transfer timing, feed formulation, fallowing, treatment and harvest. In Q2 2026, the region earned DKK 411 million of all-inclusive operational EBIT, or DKK 15.38/kg. The figure includes internal contributions allocated across FOF, freshwater, farming, services and Sales & Other. It is more economically meaningful than adding segment profits as if each were an independent external business. [S1]

Scotland is a similar intended system but not a similar economic outcome. Bakkafrost acquired the Scottish Salmon Company in October 2019 for its farming sites, licences, processing capacity and premium-origin brands. It has subsequently invested in Applecross freshwater capacity, vessels, site infrastructure and processing. The strategic proposition is to transfer Faroese large-smolt and operating practices to Scotland. In 2025, however, the Scottish region lost DKK 376 million, or DKK 16.24/kg, and in Q2 2026 it lost DKK 139 million, or DKK 44.13/kg. [S1][S2][S12][S13]

The regional result is economically more useful than the farming segment alone. Internal feed and services are priced using market references where available or benchmarking estimates. That approach is reasonable for management accounting, but transfer pricing can relocate profit among FOF, freshwater, farming and services without changing consolidated cash. In Q2 2026, for example, virtually all feed was sold internally while FOF operational EBIT increased. That may reflect genuine feed advantage, inventory timing or transfer pricing; public information cannot isolate each mechanism. [S1][S2]

The business owns scarce regulatory assets. Faroese marine licences are rolling 12-year licences covering defined fjord areas. There is no formal maximum biomass per site, but production plans require approval, one generation is permitted at a time, full harvest is required before restocking and at least two months of fallowing is mandatory. Scottish licences are site-specific, subject to biomass and environmental constraints, while Crown Estate leases are generally renewable for 25 years. These permissions are difficult to replicate and create barriers, but renewal remains conditional on biological, environmental and welfare compliance. [S2]

The accounting treatment deserves precision. At year-end 2025, total intangible assets were DKK 4.509 billion; goodwill was not an additional DKK 0.9 billion outside that amount. Goodwill of approximately DKK 580 million, licences of DKK 3.820 billion, brands of DKK 108 million and software were included within the DKK 4.509 billion total. The draft’s addition of separate goodwill double-counted assets. Licences and relevant brands are treated as indefinite-lived and tested annually rather than amortized. [S2]

Unrecognized-assets answer: Valuable assets not fully recognized at historical cost include biological data, feed formulation, broodstock and smolt know-how, fallowing and treatment routines, customer relationships, Faroese provenance and a coordinated vessel network; however, acquired licences, brands and goodwill are already substantially recognized within intangible assets. [S2][S4]

Brand economics are supportive rather than load-bearing. All salmon is sold under Bakkafrost’s main brand, with sub-brands including Heimland, Native Hebridean and Lochlander used for origin, quality or channel positioning. Provenance, traceability and specification can improve channel access and occasionally realization. Yet management reported that the premium for large fish had been largely absent for three quarters before beginning to recover. Sales & Other EBIT/kg also fell in Q2 despite much higher volume. Brand value therefore must be demonstrated through retained price premium, customer economics and repeat purchasing, not inferred from brand names. [S1][S4]

The working-capital cycle is long. Cash is spent on eggs, smolt, feed, labor, treatments and fixed assets before salmon reaches harvest weight. A biological event can destroy both future volume and capital already embedded in live fish. Larger smolt can reduce time at sea, but transfers risk and capital into land-based hatcheries. A hatchery incident can impair a concentrated future cohort, as Applecross demonstrated in 2025. Integration therefore reduces some coordination risks while internalizing more fixed assets and concentration risk.

The unit model can be summarized as follows: the number and weight of smolt determine starting capacity; survival, feed conversion, growth and sea days determine kilograms and production cost; licences and site availability constrain output; fish size, grade and harvest timing determine realization; contract and processing mix affect price stability; and asset utilization determines how fixed hatchery, vessel and processing costs are spread. The ultimate measure is not tonnes or EBIT/kg alone but after-tax cash return on licences, biomass, hatcheries, vessels and working capital.

Security-tax-status answer: BAKKA is a directly listed Faroese ordinary equity, not an ADR, MLP, partnership or K-1 issuer; foreign investors should verify withholding and treaty treatment for their own domicile. [S2][S11]

Verdict: The operating model is understandable and the Faroese system has produced tangible biological and unit-cost advantages. Revenue remains transactional, customer switching barriers are modest, Scotland has not reproduced Faroese returns, and the large recognized licence base must ultimately be justified by consolidated cash returns. [S1][S2]

Industry Dynamics

Market-growth-and-geography answer: Farmed Atlantic salmon is an international market of about 2.84 million tonnes gutted weight, or roughly 3.16 million tonnes whole-fish equivalent, in 2025; production is concentrated in a few cold-water coastal regions while demand is globally distributed. [S2][S10]

Weight basis matters. Mowi estimated 2025 global Atlantic salmon harvest at 2.8415 million tonnes gutted weight, up 12.1%. Bakkafrost and Kontali presented approximately 3.16 million tonnes on a whole-fish-equivalent basis. These estimates describe broadly the same market after conversion; they are not contradictory figures. Bakkafrost’s separate 5.39-million-tonne table covers all salmonids, including trout and wild Pacific species, and must not be mistaken for farmed Atlantic salmon. [S2][S10]

Mowi estimated the 2025 farm-gate market at about EUR 21 billion, up 5%, while global consumption increased roughly 10% and the blended price declined about 5%. These are producer estimates rather than independently audited market statistics. They nevertheless fit the observed mechanism: unusually high availability stimulated consumption but reduced unit prices. Mowi’s March forecast called for about 1% supply growth in 2026 and 1–2% annually thereafter. Bakkafrost’s August update expected full-year 2026 harvest growth of 2–3% excluding inventory, reflecting later information and potentially different datasets. The contradiction should remain visible rather than averaged into false precision. [S1][S10]

Production is geographically constrained. Atlantic salmon requires suitable water temperature, oxygen, currents, depth, shelter and environmental carrying capacity. Norway and Chile dominate supply; Scotland, the Faroe Islands, Canada, Ireland and Iceland are meaningful smaller regions. Suitable sites require regulatory permission and infrastructure. Those constraints limit greenfield entry but do not prevent existing farmers from producing cyclical gluts through better survival, heavier harvest weights, synchronized smolt transfers, warmer temperatures or higher utilization of licensed capacity.

Demand is international. In Q2 2026, Bakkafrost directed 31% of Faroese sales to North America, 15% to Asia and 47% to Western Europe. Lower prices supported consumption, and the United States, Europe and China all absorbed more salmon during 2025. Consumers nevertheless can substitute chicken, pork, whitefish, shrimp and other proteins. Structural health and convenience trends do not protect a producer when supply growth exceeds demand or when inventories are released. [S1][S2][S10]

Industry-profitability-and-barriers answer: Salmon farming can earn attractive returns when supply is tight and biology stable, but profit is cyclical and widely dispersed; barriers include scarce licences, suitable sites, freshwater and feed capacity, biological expertise, vessels, working capital, regulation and customer access. [S2][S7][S8][S9]

The industry profit pool is divided among genetics and roe, feed, freshwater production, marine farming, treatment and wellboat services, harvesting, processing, logistics, wholesale and branded distribution. Farming captures the scarcity value of licences during tight markets but bears mortality and biomass risk. Feed can be steadier but is exposed to marine-ingredient and agricultural-input prices. Processing generally earns lower margins and depends on throughput, yield and contract discipline. Branded distribution can stabilize channels but requires marketing and retailer bargaining power.

Bakkafrost internalizes nearly every stage. Integration can reduce coordination failures, secure feed and align smolt transfers with site availability. It can also trap capital in underutilized hatcheries, vessels and processing plants. The economic question is whether avoided supplier margin, better biology and higher utilization exceed the additional fixed capital and loss of supplier optionality. The Faroese results support that proposition; Scotland presently contradicts it.

The capital cycle remains powerful despite licence scarcity. High salmon prices encourage smolt production, site investment and biomass growth. Because fish take time to reach harvest weight, supply responds with a lag. When multiple farmers harvest together, prices fall quickly while depreciation, vessels, labor and site costs remain. The 12.1% increase in 2025—far above Mowi’s estimated 3% ten-year average—showed that incumbent productivity can create oversupply without new licences. Lower prices then reduce investment, encourage inventory clearance or alter harvest timing, setting up a later tightening.

Competition-direction answer: Competition intensified in 2025 as unusually high supply and inventories pressured reference prices and large-fish premiums; forecast growth is moderating, but better incumbent biology and expansion within existing licences keep rivalry structurally high. [S1][S2][S10]

Scale is valuable but not decisive. Mowi harvested approximately 559,000 tonnes in 2025 and estimates a global share near 20%. Bakkafrost’s 2026 guidance is 117,000 tonnes. Mowi, SalMar and Lerøy can diversify incident risk across more sites, negotiate inputs, optimize harvest timing and serve global customers. Bakkafrost’s compact Faroese system may offer tighter coordination, but a regional event is more concentrated. Scotland shows that ownership of sites and infrastructure does not guarantee scale economies when biomass and hatchery utilization are low.

Regulation creates both barriers and rent-sharing. The Faroese state does not require a simple upfront licence payment, but marine farming faces a reference-price revenue tax and an additional 12% corporate tax. The revenue-tax range is 0.5–7.5% under the 2025 regime, with a production-cost benchmark and SISALMONI price reference. Scotland imposes site, biomass, environmental and Crown Estate constraints. Sea-lice, welfare, benthic and fallowing rules restrict how quickly physical assets can be utilized. [S2][S6]

There are several economically relevant competitors. Mowi is the largest integrated global farmer. SalMar is a scaled Norwegian producer with meaningful Scottish exposure through Scottish Sea Farms. Lerøy combines farming, downstream operations and wild catch. Cermaq, Grieg, Australis, Cooke and large Chilean producers also affect supply. Peer accounting differs: SalMar’s Q2 group EBIT/kg was NOK 15.1 while NOK 17.2 related to Norway; Lerøy’s NOK 5.3 was farming-only and NOK 11.3 represented the closer integrated value-chain measure. Careless denominator mixing can reverse apparent rankings. [S7][S8][S9]

Foreign-low-cost-threat answer: Low-wage foreign entry cannot readily reproduce Faroese sites because licences, cold-water biology and logistics constrain location, but lower-cost output from Norway, Chile or other licensed regions can pressure the same global selling price. [S2][S10]

The threat is not classic labor arbitrage. Feed, mortality, growth, licence utilization, quality, freight and currency matter more than wages alone. A Chilean or Norwegian producer does not need to enter the Faroes to undermine Bakkafrost; incremental global volume lowers reference prices. Currency can also change relative cost and realization because sales are global while many costs are local.

Barriers therefore support capacity scarcity without eliminating rivalry. Multiple scaled farmers sell a product tied to reference prices, and buyers can compare origin, grade, specification and delivery. Provenance and certification segment portions of demand but do not create software-like lock-in. The industry structure is best described as scarce licensed capacity with cyclical incumbent competition.

Verdict: Long-run geographic constraints and international demand are supportive, but the 2025 supply surge disproves a simplistic scarcity thesis. Industry economics depend on the capital cycle and biological dispersion; efficient incumbents can earn attractive returns while poor sites destroy capital in the same market. [S2][S7][S10]

Competitive Position

Nature-of-competition answer: Salmon farmers compete on survival, feed conversion, biological cost, harvest timing, fish size and grade, reliability, origin, logistics, contract terms and processing capability; market reference prices constrain pure brand pricing power. [S1][S2][S7]

Bakkafrost’s strongest advantage is the Faroese system rather than any single brand. Havsbrún provides feed formulation and marine-ingredient inventory. Large-smolt hatcheries shorten sea exposure. Treatment vessels allow freshwater intervention. Harvesting, packaging, air freight and global sales can coordinate realization. In Q2 2026, virtually all feed was consumed internally and existing fishmeal inventory was expected to support feed production into Q2 2027. Management correctly acknowledged that integration provides flexibility rather than immunity from ingredient inflation. [S1][S4]

Financial and biological outcomes support a Faroese advantage. The region’s Q2 all-inclusive operational EBIT was DKK 15.38/kg, harvest increased 67%, average weight reached 5.5kg and ring-site cost declined roughly 4%. Services earned DKK 35 million as higher biomass increased vessel utilization. Management reported low mortality and controlled sea lice. These results are the type of evidence a moat should produce: better survival, heavier fish, lower unit cost and more efficient fixed-asset use. [S1]

The proof is regional, not automatically transferable. Scotland owned similar pieces of the value chain but lost DKK 44.13/kg. Management attributed part of the result to the deliberate reduction in harvest while Applecross ramps, but a de-risking strategy that creates years of underutilization still imposes an economic cost. Mowi earned EUR 1.80/kg on Scottish-origin salmon in the same quarter, with improving survival, feed conversion, harvest weight and superior-grade share. That is strong contradictory evidence against treating Scotland’s loss as a geography-wide normal. [S1][S7]

Transfer pricing creates an analytical trap. FOF, freshwater, services and Sales & Other conduct substantial internal business. Increasing an internal feed or smolt price can move EBIT among segments without altering group cash. Bakkafrost states that direct market prices or external benchmarks are used where possible, but many specialized services lack perfect arm’s-length comparators. Competitive analysis should therefore prioritize all-inclusive regional EBIT/kg, incident costs, cash flow and invested-capital returns. [S1][S2]

Switching-costs answer: Customers face qualification, specification and logistics costs but little hard lock-in; the more meaningful switching costs are internal because owned feed, hatchery, vessels and processing are optimized as one production system. [S1][S2]

Retailers and foodservice buyers value traceability, reliable delivery, certification, quality and consistent cuts. Switching an approved supplier can require audits, testing and logistics changes. Nevertheless, Mowi, SalMar, Lerøy and other producers offer substitutable salmon, and Bakkafrost retains substantial spot exposure. Customer switching cost is therefore modest. Internal integration is harder to copy quickly, but it also makes underutilized assets expensive and can reduce the option to procure cheaper outside services.

Brand-relevance answer: Faroese and Scottish provenance brands can improve channel access and occasional premiums, but the recent disappearance of the large-fish premium demonstrates that brands and size do not override industry supply. [S1][S4]

The Bakkafrost, Heimland, Native Hebridean and Lochlander names can communicate origin, welfare and culinary consistency. Yet Q2 Sales & Other EBIT/kg declined from DKK 4.19 to DKK 3.82 even as volume increased, and management linked weaker premiums to high availability of large superior-quality fish. A durable brand asset should be assessed through price realization relative to comparable origin, retention, repeat business and contribution after processing and freight. Those metrics are not separately disclosed.

Licences and site knowledge are stronger barriers. Faroese fjord rights, local current and disease data, fallowing history and treatment routines take years to reproduce. Scottish permissions also have scarcity value, although idle or poorly performing sites show that legal access is not equivalent to economic capacity. A licence earns a moat premium only when it supports superior after-tax cash returns.

Peer data frame the position. Mowi generated EUR 1.54/kg at group level in Q2 and EUR 1.80/kg in Scotland. SalMar generated NOK 15.1/kg at group level and NOK 17.2/kg in Norway. Lerøy generated NOK 5.3/kg in farming and NOK 11.3/kg across farming plus market operations. Bakkafrost’s group all-inclusive result was DKK 9.12/kg, equivalent to roughly NOK 13.36 at the quarter’s average exchange rate; its Faroese result was roughly NOK 22.5/kg and Scotland roughly negative NOK 64.7/kg. The Faroese core compares favorably, while the group does not merit valuation as if every region had Faroese economics. [S1][S7][S8][S9]

Verdict: Bakkafrost has a defensible Faroese advantage grounded in scarce sites, biological execution and coordination. Brand and customer switching costs are secondary. Scotland is direct evidence that licences and vertical integration are insufficient without robust cohorts and high asset utilization. [S1][S2][S7]

Growth History and Forward Opportunities

Product-outlook answer: Growth depends on smolt number and weight, shorter marine cycles, improved Scottish survival, higher site utilization, expanded feed capacity and selective processing—not on a fundamentally new product category. [S1][S2]

Harvest rose from 73,006 tonnes in 2023 to 90,656 in 2024 and 106,823 in 2025. Management guides to 117,000 tonnes in 2026, comprising 97,000 in the Faroe Islands and 20,000 in Scotland, and retains targets of 145,000 tonnes in 2028 and 162,000 in 2030. H1 2026 harvest was 61,231 tonnes, or 52% of full-year guidance. Historical tonnes are facts; 2026–30 volumes are management estimates contingent on biology, projects and markets. [S1][S2]

The DKK 5.0 billion 2026–30 programme is designed to reduce biological risk, raise efficiency and enable volume. Approximately DKK 2.2 billion is assigned to the Faroes, DKK 1.3 billion to Scotland and DKK 1.6 billion to shared farming services, subject to rounding. Projects include Skálavík, feed capacity, Scottish site and processing investment, treatment vessels and DKK 245 million of energy-transition spending. Management acknowledged that projects had been re-timed after weaker 2025–26 markets while leaving the terminal target unchanged. That increases schedule density later in the plan. [S1][S4]

Skálavík increases intended Faroese capacity from about 18 million to 24.4 million smolt of 500g. The first eggs entered in June 2026; the first commercial smolt are expected near the end of 2027. Physical start-up is therefore not the same as output. Existing Faroese evidence is encouraging: H1 transfer weight averaged 467g, post-transfer survival tracked near the high end of historical experience, and marine performance was strong. The inference that those results persist at greater scale still requires evidence. [S1][S4]

Applecross is the pivotal opportunity and risk. H1 Scottish transfers increased to 4.9 million from 1.5 million. In Q2, internally produced Applecross smolt averaged 219g while all Scottish smolt averaged 137g because external supply was smaller. Applecross utilization was only around 35%, with full production and stocking expected around Q2 2027. More and larger smolt should shorten sea cycles, restore site use and spread freshwater, vessel and processing costs over more kilograms. [S1][S4]

The adverse evidence is substantial. Applecross suffered a 2025 biosecurity incident, culling and a direct DKK 52 million effect. Management changed oversight of Scottish freshwater. In Q2 2026, one externally sourced cohort caused biological problems at Sgian Dubh and Ardyne. Internally produced fish being larger does not prove superior post-transfer survival or fully allocated return. Applecross itself adds depreciation and concentrates risk in land-based capacity. [S1][S2]

The Q2 2025 transcript provides a useful expectation benchmark. Management described an early Applecross cohort as potentially transformative and expected gradual biological and cost improvement during the following year. Twelve months later, utilization was still 35% and Scottish all-inclusive loss had worsened per kilogram. The long biological lag explains some delay, but it also shows why management enthusiasm should update probability only after cohort evidence. [S4][S5]

FOF growth is mostly captive. Feed sales were 165,174 tonnes in 2025 and guidance increased to about 175,000 tonnes for 2026. Close to all expected output will be sold internally. Marine raw-material intake fell 40% in H1 2026 and ingredient prices increased, while inventory supported supply security. Feed expansion can create resilience and formulation flexibility; it does not create independent external growth unless arm’s-length demand and returns emerge. [S1][S2]

Sales growth can come from geography and mix. North America and Asia gained share in Q2 and VAP represented about 25% of Faroese volume. The revised tax regime may eventually improve the economics of contracting and processing, but management still targeted only 15–25% contract coverage. Processing growth creates value only if premium and throughput exceed conversion, freight and tax costs.

A decision-useful growth scorecard should include smolt number and weight, post-transfer survival, sea days, biological feed conversion, incident cost, superior-grade share, harvest tonnes, all-inclusive EBIT/kg, operating cash after capex and net debt. Tonnes without cash return can destroy value.

Verdict: The physical path toward 162,000 tonnes is plausible, with higher confidence in Faroese expansion than Scottish normalization. Growth should receive valuation credit only as cohorts translate investment into survival, unit cost, capital turns and cash. [S1][S2][S4]

Financial Quality

Earnings-cycle answer: 2025 was likely nearer a salmon-price trough than a peak because global supply grew about 12%, but group earnings were not a clean industry trough—Faroese operations remained strong while Scottish losses were company-specific. [S1][S2][S10]

The five-year reported record is cyclical. Revenue rose from DKK 5.554 billion in 2021 to DKK 7.130 billion in 2022, DKK 7.141 billion in 2023 and DKK 7.334 billion in 2024, then fell to DKK 7.007 billion in 2025. Operational EBIT moved from DKK 821 million to DKK 1.705 billion, DKK 1.544 billion, DKK 1.550 billion and DKK 888 million. Operational EBITDA was DKK 1.352 billion, DKK 2.243 billion, DKK 2.181 billion, DKK 2.254 billion and DKK 1.673 billion. The 2025 margin compression occurred despite an 18% increase in harvest, demonstrating negative price and mix leverage. [S2]

IFRS results differed because live biomass is fair-valued. Detailed 2025 statements reported operational EBIT of DKK 887.5 million, positive biological fair-value adjustment of DKK 128.1 million, associate income of DKK 36.1 million and revenue tax of DKK 173.9 million, producing IFRS EBIT of DKK 877.8 million and total profit of DKK 523.8 million. In 2024, operational EBIT was DKK 1.550 billion but a negative DKK 368.9 million biomass adjustment and DKK 221.9 million revenue tax reduced IFRS EBIT to DKK 1.006 billion. [S2]

H1 2026 improved. Revenue rose to DKK 3.939 billion from DKK 3.474 billion, operational EBITDA to DKK 1.244 billion from DKK 952 million and operational EBIT to DKK 816 million from DKK 570 million. IFRS EBIT was DKK 278 million versus negative DKK 81 million, and profit was DKK 146 million versus a DKK 144 million loss. Q2 alone generated DKK 273 million of operational EBIT but negative DKK 192 million of IFRS EBIT because the biomass fair-value adjustment was negative DKK 406 million and revenue tax was DKK 58 million. [S1]

Business-profitability answer: Reported 2025 ROCE was 5.1%, down from 9.1% in 2024, while Company Financials estimated ROIC at approximately 4.4%; both are below a reasonable equity-funded cost of capital despite attractive Faroese unit economics. [S2][S11]

Definitions matter. Bakkafrost’s ROCE uses operational EBIT divided by average capital employed, defined as total assets less current liabilities. It therefore excludes recurring revenue tax from the numerator. Company Financials uses a standardized ROIC calculation based on reported financials and estimated roughly 10.5% in 2022, 7.2% in 2023, 4.9% in 2024 and 4.4% in 2025. Exact peer rankings are unreliable because biological fair value, associates, tax and capital definitions vary, but the direction is clear: consolidated returns weakened as Scotland and the asset base remained underproductive. [S1][S2][S11]

Operational EBIT is useful but incomplete owner economics. It removes volatile biomass marks, onerous-contract provisions, associate income and the Faroese revenue tax. Removing unrealized biomass movements improves period comparability. Excluding a recurring production tax is more contentious because the tax is a cash cost of accessing Faroese marine farming. The draft incorrectly stated that 2025 revenue tax was DKK 222 million; the verified figure is DKK 174 million, while DKK 222 million related to 2024. H1 2026 revenue tax was already DKK 148 million. [S1][S2][S6]

Accounting-conservatism answer: IFRS recognition is conventional, but Level 3 biomass valuation, indefinite-lived licences and management’s exclusion of recurring revenue tax from operational EBIT require investor normalization; the accounts are neither mechanically conservative nor demonstrably aggressive. [S1][S2]

Biomass is carried at fair value less costs to sell when reliably measurable. Year-end 2025 biological assets were DKK 3.422 billion and included about DKK 501 million of fair-value uplift. Price, weight, harvest timing, quality and mortality assumptions can change IFRS EBIT before cash is realized. Operational EBIT removes that mark, but investors must retain realized mortality, treatment, working capital and production tax.

The Q2 2026 report was corrected because regional operating expense had been misclassified as depreciation in the appendix. The correction changed neither EBIT nor EBITDA, regional or group results, cash flow, balance sheet, guidance nor KPIs. This is a disclosure-control blemish rather than evidence of profit overstatement. The interim statements were not audited or reviewed, so audited annual figures should govern where classifications conflict. [S1][S14]

Intangibles require skepticism. The DKK 4.509 billion total included DKK 3.820 billion of licences and DKK 580 million of goodwill. Licences are treated as indefinite-lived based on renewal history and conditions; goodwill and licences are tested annually. No material Scottish impairment was recognized in 2025 despite regional losses. That may reflect credible long-term cash-flow expectations, but non-impairment is not evidence that the acquisition has earned its cost of capital. [S2]

Income-cash-divergence answer: Operating cash exceeded net income in 2024 and 2025 because depreciation, biomass marks and working-capital movements differ from earnings, but heavy capital expenditure and lease payments absorbed most of the apparent advantage. [S1][S2]

In 2025, operating cash was DKK 1.079 billion versus total profit of DKK 524 million. Capital expenditure was DKK 1.135 billion, so free cash flow before lease principal was negative DKK 56 million; after DKK 172 million of lease payments it was approximately negative DKK 229 million. The group nevertheless paid DKK 501 million of dividends relating to 2024 and increased interest-bearing debt. In 2024, operating cash of DKK 2.355 billion comfortably exceeded DKK 1.026 billion of gross fixed-asset spending, illustrating cyclicality and working-capital sensitivity. [S2]

Trailing through June 2026 is better than the draft indicated. Subtracting H1 2025 from FY2025 and adding H1 2026 yields operating cash of about DKK 1.419 billion and capex of DKK 1.034 billion: approximately DKK 385 million before lease principal. Estimated trailing lease payments of roughly DKK 175 million reduce this to DKK 210 million. That is positive, but only about 1.1% of current equity value in DKK. [S1][S2][S16]

Capital-intensity answer: The business is highly capital intensive because licences, hatcheries, live biomass, feed inventory, marine sites, processing plants and vessels absorb capital well before harvest cash is received. [S1][S2]

At June 2026, Bakkafrost carried DKK 7.259 billion of property, plant and equipment, DKK 726 million of right-of-use assets, DKK 2.950 billion of biological assets and DKK 1.238 billion of non-biological inventory. Intangible licences and goodwill added another DKK 4.514 billion. The DKK 5 billion investment programme exceeds five times 2025 operational EBIT before production tax. Returns therefore depend as much on capital turns as on EBIT/kg. [S1][S2]

The balance sheet is adequate but not cash-rich. June equity was DKK 10.964 billion, or 58% of assets. Cash was DKK 327 million, gross interest-bearing debt DKK 4.368 billion and lease liabilities DKK 788 million. Net interest-bearing debt excluding leases was DKK 4.040 billion, approximately 2.1x trailing operational EBITDA; including leases it was roughly 2.5x. Undrawn committed facilities were approximately DKK 1.3 billion plus an accordion. [S1]

Off-balance-sheet-liabilities answer: Material economic obligations include committed projects, Crown Estate leases, raw-material procurement, environmental compliance, site maintenance and restoration; IFRS 16 recognizes most lease debt, and no material unconsolidated financing vehicle was identified. [S1][S2]

The group’s bank financing is secured by licences, property, equipment, subsidiaries, inventory and receivables, with group guarantees. Liquidity can therefore deteriorate nonlinearly if biology and price weaken during the investment cycle. The present equity ratio and facilities provide resilience, but not unlimited capacity.

Verdict: Financial quality is bifurcated. Faroese biology supports strong unit economics, but consolidated ROCE and ROIC remain sub-cost-of-capital. Cash flow has improved and is not zero, yet production tax, lease principal and heavy reinvestment leave a low distributable yield. [S1][S2][S11]

Capital Allocation

Free-cash-flow-and-use answer: Bakkafrost generated negative DKK 56 million of 2025 free cash flow before lease principal and approximately negative DKK 229 million after leases, while paying DKK 501 million of dividends; trailing cash flow improved, but reinvestment remains the dominant use. [S1][S2]

Management’s allocation programme prioritizes biological resilience and growth. The group invested DKK 1.135 billion in fixed assets during 2025 and plans DKK 5 billion for 2026–30. Hatcheries, feed capacity, treatment vessels and processing can lower risk or expand volume, but strategic description is not a return threshold. The relevant evidence is incremental survival, cost, throughput and cash return by project.

Acquisition-record answer: The 2019 Scottish Salmon Company acquisition added scarce licences, brands and capacity, but subsequent losses and remedial capital spending show that demonstrated returns remain materially below the original ambition. [S1][S2][S12][S13]

Bakkafrost initially acquired 68.6% for NOK 3.761 billion and financed the transaction partly through a 7.329-million-share placement at NOK 500, with further seller-settlement shares contemplated. The transaction materially increased the share base. The strategic thesis—premium Scottish origin plus transfer of Faroese methods—was coherent, but six years of ownership followed by a DKK 376 million 2025 regional loss means it cannot be described as an early integration story. [S12][S13]

The correct forward question is incremental rather than sunk-cost based: whether remaining Applecross, site and processing expenditure can earn an acceptable return. Still, historical acquisition and follow-on capital belong in any research-adjusted return calculation. Excluding both the past purchase consideration and remedial capex would make the turnaround appear artificially attractive.

Share-repurchase answer: Bakkafrost has no material discretionary capital-return buyback; 2025 treasury activity primarily supported employee programmes, and year-end net outstanding shares were effectively flat. [S2][S3]

The company issued 85,122 shares in 2025, purchased 100,000 treasury shares and sold 5,917 treasury shares for employee arrangements. Net outstanding shares fell from 59,303,397 to 59,294,436. Treasury holdings were 95,305 at year-end. These amounts are immaterial to per-share value, although they should not be confused with a valuation-driven repurchase programme. [S2]

Insider-share-issuance answer: Employee and executive equity issuance is small relative to total shares; the historically important dilution was acquisition financing rather than current compensation. [S2][S3][S12]

The employee savings and bonus programmes use restricted and matching shares. Management purchases disclosed under the savings plan are payroll-linked and should not be characterized as large discretionary open-market insider buying. Share-based personnel expense was DKK 31 million in 2025, and the net share count remained nearly flat. [S2][S3]

Compensation-policy answer: Executive variable pay is capped at 100% of base salary and uses one- and three-year components weighted mainly to regional EBIT/kg and fish survivability, with feed conversion and group EBIT/kg also included. [S3]

For 2025, regional EBIT/kg and survivability each carried 40% weight, biological feed conversion 10% and group EBIT/kg 10%. The employee bonus pool requires adjusted quarterly EPS above DKK 2 and is funded with 3% of adjusted profit. Ownership guidelines effective from 2026 target 200% of salary for the CEO and 100% for other executives over five years. These metrics are relevant to biological value creation, although EBIT/kg can still reward volume or internal allocations without proving capital return. [S3]

Management-motivation answer: CEO Regin Jacobsen’s approximately 7.84% ownership aligns him with long-term per-share value, while long tenure and a 24-month notice period create some entrenchment and perseverance risk. [S2][S3]

The CEO held 4,656,515 shares at year-end 2025. That position dwarfs annual compensation and reduces concern about short-term extraction. The counter-risk is commitment to a long-held Scottish thesis: ownership alignment can encourage patient value creation, but it can also delay restructuring or disposal of an underperforming asset. Board willingness to impose project-level return gates matters.

Dividend-policy answer: The board targets 30–50% of adjusted EPS subject to a healthy capital base; the DKK 3.45-per-share 2025 dividend equaled 50% of adjusted EPS but was not covered by 2025 free cash flow. [S1][S2][S3]

The dividend was paid in May 2026 as NOK 5.06 per share, an indicated yield of about 1.1% on NOK 448.20. The reduction from DKK 8.44 was appropriate given weaker adjusted earnings. Paying the top of the policy range during a capex cycle is less conservative than a cash-based distribution rule.

Verdict: Capital allocation is credible in intent but not demonstrated in return. Management is economically aligned and current dilution is small, yet Scotland remains a poor historical acquisition, reinvestment exceeds normalized distributable cash and the dividend formula can require borrowing when accounting earnings exceed cash. [S1][S2][S3]

Changes and Headwinds — Last Two Years

Environment-change answer: The last two years brought a redesigned Faroese tax regime, exceptional 2025 supply growth, lower prices, Scottish disease and hatchery setbacks, strong Faroese biology and a new DKK 5 billion investment programme. [S1][S2][S6][S10]

The external environment moved from constrained supply to a 12.1% increase in 2025 Atlantic salmon harvest. Reference prices weakened and the large-fish premium compressed. In Q2 2026, 4–5kg reference prices were 0.6% lower year over year and 15.7% lower sequentially. Inventory releases meant supplied volume grew 6.7% even though harvest grew only 3.3%. Bakkafrost expected H2 harvest to decline about 1%, while Mowi’s earlier annual forecast expected about 1% full-year growth. Forecast dispersion remains material. [S1][S10]

External-versus-internal-drivers answer: Salmon prices, marine-ingredient inflation and currencies are external; the Faroese–Scottish performance gap, Applecross utilization, smolt quality, fallow-site cost and fixed-cost absorption are principally internal execution variables. [S1][S4][S7]

This distinction prevents inappropriate normalization. Faroese profit remained positive under the same global price. Mowi’s Scottish operation was profitable under broadly similar geography and regulation. Consequently, Scottish losses cannot be dismissed as unavoidable market conditions.

Tax visibility improved but the state’s economic claim remains. The old tax could reach 20% of reference-price revenue and undermined fixed contracts. From 2025 the cap fell to 7.5%, the reference changed to SISALMONI and Faroese marine farming became subject to an additional 12% corporate tax. The broad agreement extends through 2032, reducing near-term political uncertainty while sharing more upside with the government. [S6]

Facilities changed materially. Applecross continued ramping after its 2025 biosecurity incident but remained only 35% utilized. Scottish freshwater oversight was strengthened. Skálavík received its first eggs in June 2026, with first smolt expected late in 2027. Treatment-vessel capacity supported Faroese lice control. Several programme investments were re-timed after weaker market conditions. [S1][S2][S4]

Markets-facilities-management answer: Sales shifted toward North America and Asia, Applecross remained underutilized, Skálavík entered biological start-up and Scottish freshwater oversight changed, while group CEO continuity remained high. [S1][S2][S4]

The latest call presented three hypotheses. Marine-ingredient inventory should improve sourcing flexibility; this is supported by inventory expected to cover feed production into Q2 2027 but not by immunity from inflation. Large smolt should de-risk Scotland; this is supported by Faroese experience but not by matched Scottish cohorts. Limited global supply should support prices; this is consistent with producer forecasts but exposed to biology, inventory and forecasting error. [S4][S10]

Accounting-policy-change answer: No material change to core IFRS policies was identified; the Q2 appendix correction reclassified regional expense between operating cost and depreciation without changing profit, cash, balance sheet or guidance. [S1][S2][S14]

IFRS 18 may alter future presentation, but management expects the principal effect to concern classification rather than measurement. Biomass fair value, licence impairment and revenue recognition were otherwise consistent with 2025 policies.

Verdict: External pricing appears to have moved past the most extreme 2025 supply shock, but company-specific Scottish execution has become more—not less—important. Tax and facility visibility improved, while schedule slippage and absent cohort disclosure remain disconfirming evidence. [S1][S4][S6]

Risk Analysis

Stock-decline-factor answer: The shares could fall through renewed salmon-price weakness, Scottish mortality, Applecross underperformance, capex overruns, slower volume growth, debt expansion, tax or licence changes, biomass write-downs, currency moves or multiple compression. [S1][S2][S6]

Catastrophic-loss answer: Catastrophic impairment would likely require correlated multi-year biological failure, sustained low prices, large Scottish impairment, continued capex and refinancing stress or loss of material farming permissions. [S1][S2]

A single bad quarter is unlikely to be catastrophic because Faroese licences, physical assets, equity and facilities retain value. The dangerous path is a feedback loop: disease reduces harvest; low harvest raises cost/kg; weak cash requires debt; committed projects continue; impairment erodes lender protection; and refinancing forces asset sales or equity issuance at a depressed price. Scotland alone is unlikely to eliminate all value, but it can consume years of Faroese cash and prevent group returns from clearing the cost of capital.

Total-loss answer: Literal total loss appears remote because profitable Faroese licences and physical assets retain recovery value; near-total equity loss would require licence revocation or simultaneous prolonged biology, price and financing failure. [S1][S2]

Climate and environmental risk operate through temperature, oxygen, storms, algae, pathogens and sea lice. Large smolt shortens marine exposure but concentrates more value in land facilities. Applecross shows that risk is transferred rather than abolished. Geographic diversification helps only if operational risks are not correlated and both regions function adequately.

Tax risk is asymmetric. High prices increase reference-price revenue tax and the additional corporate tax shares Faroese upside with the state. At low prices a minimum levy remains. Operational EBIT excludes the revenue tax, so headline sensitivity understates the government’s economic claim. Fixed contracts can still create reference-price mismatches.

Governance risk is perseverance rather than obvious extraction. Substantial CEO ownership aligns ultimate value but may encourage further Scottish investment to validate a strategic commitment. A credible mitigation would be a disclosed return threshold and willingness to slow, partner, restructure or sell if matched cohorts fail.

Dilution risk is currently low but historically demonstrated. The Scottish acquisition used substantial new equity. If leverage and capex rise while Scotland remains negative, another issuance could return. A stable recent share count is not a permanent protection.

Verdict: Downside is dominated by correlated biology, price and capital-allocation risks. Balance-sheet strength reduces near-term failure probability, but Scotland can convert a normal cycle into a prolonged value trap if investment continues ahead of biological proof. [S1][S2]

Valuation Discussion

At the verified 11 September 2026 close of NOK 448.20 and 59,389,741 issued shares, market capitalization was approximately NOK 26.62 billion. Using Norges Bank’s NOK 144.22 per DKK 100 rate, equity value was about DKK 18.46 billion. Subtracting treasury shares would reduce that figure by less than 0.2%, so issued-share convention does not affect the conclusion. [S11][S16]

June net interest-bearing debt was DKK 4.040 billion and lease liabilities DKK 788 million. Enterprise value is therefore approximately DKK 22.50 billion excluding leases and DKK 23.29 billion including them. Lease convention must be paired with the earnings denominator: an EBITDA multiple that includes lease debt but ignores lease-related expense differences can mislead. [S1]

Trailing operational EBIT through June is reconstructed as FY2025 DKK 887.5 million minus H1 2025 DKK 570.1 million plus H1 2026 DKK 816.4 million, or DKK 1.134 billion. Operational EBITDA is approximately DKK 1.965 billion. Adjusted profit is approximately DKK 597 million. These are analyst calculations from reported periods, not company-supplied trailing figures. They imply:

Company Financials’ Q2-date standardized EV/EBITDA estimates were approximately 11.2x for Mowi, 14.1x for SalMar and 8.7x for Lerøy. Bakkafrost’s current 11.5x estimate sits between them. The comparison is directional because Mowi’s Nova Sea acquisition, SalMar’s equity-accounted Scottish Sea Farms interest and Lerøy’s wild-catch operations affect enterprise value and EBITDA differently. [S11]

Peer operating results also differ. Mowi’s Q2 group operational EBIT/kg was EUR 1.54, SalMar’s NOK 15.1 and Lerøy’s integrated farming-plus-market result NOK 11.3. Bakkafrost’s Faroese DKK 15.38/kg was superior after currency translation, while consolidated DKK 9.12/kg was not. A premium multiple is defensible only if the Faroese mix dominates and Scotland ceases destroying returns. [S1][S7][S8][S9]

Own-history multiples appear lower than several 2021–25 year-end snapshots, but historical percentiles are fragile. Scotland changed the business mix, biological fair value changes the denominator, and the investment programme changes capital intensity. The retrieved learning that valuation percentiles must be recomputed after a large price gap is valid here: the 31 August decline changed the current percentile, but a lower percentile does not establish intrinsic value. [S1][S11]

Three scenarios make the embedded expectations explicit. They are estimates, not forecasts:

Using an 11% cost of equity, a late-2029 valuation point and conservative interim distributions gives approximate present values of NOK 145–170 in the bear case, NOK 535–570 centrally and NOK 950–1,000 in the bull case. The ranges are deliberately wide because terminal margin is more important than small changes in discount rate. Weighting the cases 35%, 50% and 15% produces approximately NOK 475–500.

The bear case is not liquidation. It values the licences but assumes capital intensity and Scottish underperformance consume much of their scarcity value. The central case uses volume below the 162,000-tonne target and an EBIT/kg level near strong integrated peers rather than Faroese peak economics. The bull case requires profitable Scottish cohorts and improved capital turns; volume alone is insufficient.

The current price embeds four propositions: salmon prices recover from the 2025 supply shock; Faroese volume grows without biological deterioration; Scotland narrows losses as Applecross fills; and the DKK 5 billion programme does not require major additional capital or equity. The market appears right to value the Faroese licences and a tighter supply outlook. It may be too optimistic about the speed of Scottish normalization and too pessimistic about the nonlinear fixed-cost benefit if Applecross succeeds.

Verdict: The stock is not expensive relative to its own history but is not distressed relative to direct peers. A roughly 1.1% after-lease trailing cash yield and sub-cost-of-capital group returns mean valuation depends on future Scottish and capital-turn improvement. [S1][S2][S11]

Variant Perception

Investor-questions answer: The most decision-useful investor questions concern Applecross utilization and cohort quality, Scottish fixed-cost absorption, marine-ingredient inventory, project timing, contract share and whether supply will actually tighten. [S1][S4][S5]

The apparent consensus is that 2025 marked a price trough, the Faroese core retains premium quality and Scotland improves as Applecross ramps. The current multiple does not price complete success, but it assigns meaningful value to recovery.

The strongest bull case is a volume-plus-cost inflection. Faroese 500g smolt preserve high survival as capacity expands. Applecross moves from 35% toward full utilization. Scottish fish spend less time at sea, site and vessel utilization improves, incident cost falls and regional EBIT becomes positive. Group harvest approaches 150,000–162,000 tonnes without proportional capital growth, allowing operational EBIT/kg and free cash flow to rise sharply after peak investment. [S1][S4]

The strongest bear case is a transferability failure. Faroese success may depend on local sites, density, institutional knowledge and biological conditions that cannot be replicated in Scotland. Applecross adds fixed cost and concentrated hatchery risk; large smolt can still fail after transfer; established producers can surprise with more supply; and the group may spend DKK 5 billion on low-return tonnes. Lack of impairment would delay accounting recognition, not preserve economic value. [S1][S2][S7]

Five assumptions carry most of the thesis:

1. Larger Scottish smolt must cause better survival and lower fully allocated cost, not merely correlate with selected cohorts.
2. Higher Scottish harvest must improve fixed-cost absorption faster than disease, feed and treatment expense increase.
3. Global supply growth must remain in low single digits after 2025.
4. The investment programme must remain near DKK 5 billion without material equity issuance.
5. Faroese survival, feed conversion and unit cost must remain strong as volume rises.

The factor model was unavailable. No model beta, alpha, momentum, value, size, quality or sector exposure is therefore claimed. This does not mean the exposures are zero. Economically, the equity is sensitive to salmon prices, biological shocks, NOK/DKK translation, marine-ingredient costs and capex duration, but those are fundamental inferences rather than factor-model outputs.

The graph review produced two useful conclusions. The existing cross-industry rule requiring valuation percentiles to be recomputed after a large price gap was revalidated with current price and denominator data. The unrelated biotechnology, banking, chemical and marketplace learnings were rejected. No Bakkafrost-specific validated learning existed, and no prior recommendation was available to score.

Verdict: The differentiated view is that Faroese quality is real and partly recognized, while Scotland should be valued as an option requiring matched cohort proof. The bull wins through survival, utilization and cash; the bear wins if tonnes increase without ROCE. [S1][S2][S7]

Fact vs. Interpretation

Several draft assumptions were stale or contradictory. The 2025 revenue-tax figure was DKK 174 million, not DKK 222 million. DKK 222 million was the 2024 charge. Total intangible assets were DKK 4.509 billion and already included approximately DKK 580 million of goodwill; adding goodwill again double-counted assets. Trailing filing-derived free cash flow was positive rather than nil, though still low after leases. The corrected exchange rate increased estimated enterprise value and multiples. [S1][S2][S16]

Scottish geography is difficult, but Mowi proves profitable farming there is possible. Skálavík’s first eggs in June 2026 should not be confused with commercial smolt output expected late in 2027. The 162,000-tonne target remains, but project timing has changed. The Q2 expense-classification correction affected presentation rather than profit or cash. [S1][S4][S7][S14]

Verdict: Verified facts establish a strong Faroese region, weak Scottish returns, adequate liquidity and low current cash yield. Scottish large-smolt causality and tighter future supply remain hypotheses. [S1][S2][S10]

Open Questions

The following questions are material because aggregate tonnes and adjusted EBIT cannot resolve biological and capital-return uncertainty. [S1][S2][S4]

1. What are survival, feed conversion, incident cost, sea days and fully allocated EBIT/kg for internal Applecross versus external smolt, matched by transfer quarter and site?
2. At what Applecross utilization does Scottish freshwater break even after depreciation and maintenance capex?
3. How much of Scotland’s loss is attributable to idle sites, vessels, mortality, feed conversion, processing under-absorption and price realization?
4. What cumulative acquisition, capex and working capital has been invested in Scotland since 2019?
5. What discount rate, volume and margin support the Scottish licence and goodwill carrying values, and what is impairment headroom?
6. Which 2026–30 projects were delayed, what are revised commissioning dates and how much inflation is included in DKK 5 billion?
7. How will operational EBIT reconcile to production tax, cash tax and free cash flow under the revised regime?
8. How much FOF profit reflects genuine input advantage versus transfer pricing?
9. What proportion of 2027 harvest is contracted and has the revised tax made value-added contracts attractive again?
10. At what leverage threshold would the board reduce dividends or postpone expansion?
11. Have directors made material discretionary purchases outside employee programmes after the price decline?
12. What evidence would cause management to restructure, partner or dispose of Scottish assets?

What Must Be True

Bull tests

• Scottish biology: Applecross must approach planned utilization and internal smolt must deliver measurably better post-transfer survival, feed conversion and sea days by the end of 2027. Falsifier: larger cohorts continue to experience material disease or mortality without lower fully allocated cost. Monitor utilization, internal transfer weight and cohort survival. [S1][S4]

• Scottish economics: Scotland must record at least two consecutive quarters of positive all-inclusive operational EBIT while incident cost and idle-capacity expense decline. Falsifier: losses persist when harvest returns above roughly 7,000 tonnes per quarter. Monitor regional EBIT/kg and the appendix allocation. [S1][S7]

• Faroese durability: Ring-site cost, survival and lice control must remain strong as harvest approaches 100,000 tonnes. Falsifier: higher stocking materially worsens mortality, feed conversion, grade or fallowing discipline. [S1][S2]

• Capital returns: The DKK 5 billion programme must remain near budget and group ROCE should move sustainably above 10% after ramp-up. Falsifier: cumulative capex rises materially while ROCE remains in mid-single digits. [S1][S2]

• Balance sheet: Operating cash must cover capex and dividends over a full cycle. Falsifier: net debt approaches three times sustainable operational EBITDA despite normalized prices. Monitor after-lease FCF and covenant headroom. [S1][S2]

• Industry: Realized supply growth must remain low-single-digit and inventory movements normalize. Falsifier: another mid-to-high-single-digit increase without matching consumption. [S1][S10]

Bear tests

• Transferability failure: Bakkafrost Scotland remains structurally worse than Mowi Scotland after Applecross reaches substantial utilization. Bear falsifier: matched cohorts converge toward profitable peer biology and cost. [S1][S7]

• Capital sink: Scotland continues absorbing Faroese cash without positive regional cash after maintenance investment. Bear falsifier: Scottish operating cash after maintenance capex remains positive for a full year. [S1][S2]

• Adjusted-profit overstatement: Operational EBIT continues diverging from cash because production tax, working capital, maintenance capex and leases absorb it. Bear falsifier: adjusted and cash returns converge across a complete price cycle. [S1][S2][S6]

• Guidance slippage: The 2028 and 2030 milestones are delayed or require materially more than DKK 5 billion. Bear falsifier: annual commissioning, capex and biomass milestones track the revised plan without equity issuance. [S1][S4]

• Valuation compression: Investors value the group closer to a lower-return asset multiple. Bear falsifier: Scottish profitability and consolidated ROCE justify a sustained premium to direct peers. [S2][S7][S8][S9]

The decisive dashboard is Scottish cohort survival and regional EBIT/kg, Faroese biological cost, cumulative capex, net debt, realized salmon price and cash ROIC. If those measures improve together, the thesis is working. If tonnes rise while cash and ROCE do not, it is falsified. The premises are anchored in the corrected Q2 2026 report, the 2025 integrated annual report and Mowi’s Q2 2026 report.

Public source appendix

• S1: Bakkafrost — Corrected Q2 and H1 2026 Interim Report — primary company interim filing; published 2026-08-31; Pages 2–8, 15–17, 23–24 and 26: results, regional EBIT/kg, guidance, balance sheet, cash flow and APM reconciliations
• S2: Bakkafrost — Integrated Annual Report 2025 — primary audited annual report; published 2026-03-27; Pages 12–55 and 191–225: strategy, licences, five-year results, segments, tax, cash flow, intangibles, debt, shares and accounting policies
• S3: Bakkafrost — Remuneration Report 2025 — primary remuneration filing; published 2026-03-27; Pages 4–15: incentive metrics, variable-pay caps, ownership guidelines, dividend and governance provisions
• S4: Company Financials — Bakkafrost Q2 2026 Earnings Call Transcript — management transcript via Company Financials; published 2026-08-31; Management presentation and Q&A: Applecross utilization, smolt weights, feed inventory, Scottish costs, supply outlook and project timing
• S5: Company Financials — Bakkafrost Q2 2025 Earnings Call Transcript — management transcript via Company Financials; published 2025-08-26; Management presentation and Q&A: Applecross cohort expectations, Scottish transition costs, biology and contract exposure
• S6: Bakkafrost — Faroese Salmon-Farming Tax Agreement — primary company/regulatory release; published 2025-01-08; Tax redesign effective 1 January 2025: prior regime, SISALMONI reference, 0.5–7.5% revenue tax and 12% additional corporate tax
• S7: Mowi — Q2 2026 Report — primary peer interim filing; published 2026-08-18; Pages 2 and 4 and Scottish-origin section: group and regional harvest, operational EBIT/kg and biological commentary
• S8: SalMar — Q2 2026 Results — primary peer release; published 2026-08-25; Q2 group and Norway harvest, operational EBIT, EBIT/kg and 2026 guidance
• S9: Lerøy Seafood Group — Q2 2026 Report — primary peer interim filing; published 2026-08-19; Pages 4–5, 8–9, 13 and 22: group results, farming and value-chain EBIT/kg, Scottish Sea Farms and guidance
• S10: Mowi — Annual Report 2025 — primary peer annual report and producer market estimates; published 2026-03-25; Pages 20 and 57–62: global Atlantic salmon harvest by region, market value, consumption, price and supply-growth outlook
• S11: Company Financials — BAKKA and Direct-Peer Market and Fundamental Data — Company Financials dataset and exchange instrument reference; published 2026-09-11; Primary symbol OSL:BAKKA; prices through 11 September 2026; multi-period statements, ratios, enterprise value and direct-peer valuation snapshots reconciled to filings
• S12: Bakkafrost — 2019 EGM Notice for Scottish Salmon Company Acquisition — primary transaction filing; published 2019-09-27; Purchase of 68.6%, consideration, placement and seller-settlement share issuance
• S13: Bakkafrost — Q4 and Full-Year 2019 Results — primary company release; published 2020-02-25; Scottish acquisition rationale, acquired operations and financing commentary
• S14: Bakkafrost — Correction to Q2 2026 Report and Presentation — primary correction notice; published 2026-08-31; Regional expense-classification error and confirmation of no effect on results, cash, balance sheet, guidance or KPIs
• S15: Bakkafrost — Reports and Presentations Archive — primary filing index; publication date unavailable; Annual and interim reports covering the trailing five years
• S16: Norges Bank — Exchange Rates — official central-bank market data; published 2026-09-11; 11 September 2026 indicative middle rate: NOK 144.22 per DKK 100